2013 parkinson's disease glutathione four authors Disease: The Epidemiology, Risk Factors, Molecular Pathogenesis, Prevention, and Therapy Glutathione metabolism and Parkinson's disease
Description
A reasonable progression involves adding 10 to 15% to weekly mileage when the previous weeks training produced no significant flare-ups
That substance was a protein, and from it, they identified a smaller substance that they believed was the active principle, or the part of the protein responsible for producing the therapeutic benefits
Zhang X, Jeong H, Niu J, Holland SM, Rotanz BN, Gordon J, et al
Cysteine S-conjugate N-acetyltransferase from rat kidney microsomes
[DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted] 72.Li H., Yao Y., Li L
Nat Genet (2000) 26:33640
